Gregory Sargen

Insider Reports History

Signature
/s/ Mary Grendell, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Sargen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avid Bioservices, Inc. Director Common Stock, $0.001 par value 0 $0 $12.37 Feb 5, 2025 Direct
Avid Bioservices, Inc. Director Restricted Stock Units 0 $0 $12.37 Feb 5, 2025 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 24K Jun 12, 2025 Direct
Avid Bioservices, Inc. Director Stock Option (right to buy) 0 Feb 5, 2025 Direct

Insider Reports Filed by Gregory Sargen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARA Protara Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 13, 2025 Director
CDMO Avid Bioservices, Inc. Feb 5, 2025 6 $0 4 Feb 7, 2025 Director
CDMO Avid Bioservices, Inc. Dec 14, 2024 3 $0 4 Dec 17, 2024 Director
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
CDMO Avid Bioservices, Inc. Dec 14, 2023 3 $0 4 Dec 18, 2023 Director
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
CDMO Avid Bioservices, Inc. Apr 11, 2023 1 -$142K 4 Apr 12, 2023 Director
CDMO Avid Bioservices, Inc. Dec 14, 2022 3 $0 4 Dec 16, 2022 Director
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
CDMO Avid Bioservices, Inc. Dec 14, 2021 3 $0 4 Dec 16, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director